Get it on Google Play

Lifeward receives European approval for ReWalk 7 exoskeleton

September 8, 2025 8:30 AM EDT Send to a Friend
Lifeward Ltd. (NASDAQ: LFWD) announced it received CE mark approval for its ReWalk 7 Personal Exoskeleton, enabling commercial sales across ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login